PMC:7358770 / 33217-33362 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T322","span":{"begin":34,"end":41},"obj":"Body_part"}],"attributes":[{"id":"A322","pred":"fma_id","subj":"T322","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"d for COVID-19 using the envelope protein of SARS-CoV-2 as an immunogenic target [124]. Carrageenan and its structurally related compounds may se"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1121","span":{"begin":45,"end":55},"obj":"Species"},{"id":"1124","span":{"begin":88,"end":99},"obj":"Chemical"},{"id":"1131","span":{"begin":6,"end":14},"obj":"Disease"}],"attributes":[{"id":"A1121","pred":"tao:has_database_id","subj":"1121","obj":"Tax:2697049"},{"id":"A1124","pred":"tao:has_database_id","subj":"1124","obj":"MESH:D002351"},{"id":"A1131","pred":"tao:has_database_id","subj":"1131","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"d for COVID-19 using the envelope protein of SARS-CoV-2 as an immunogenic target [124]. Carrageenan and its structurally related compounds may se"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T141","span":{"begin":6,"end":14},"obj":"Disease"},{"id":"T142","span":{"begin":45,"end":53},"obj":"Disease"}],"attributes":[{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A142","pred":"mondo_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"d for COVID-19 using the envelope protein of SARS-CoV-2 as an immunogenic target [124]. Carrageenan and its structurally related compounds may se"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T494","span":{"begin":34,"end":41},"obj":"Chemical"},{"id":"T495","span":{"begin":88,"end":99},"obj":"Chemical"}],"attributes":[{"id":"A494","pred":"chebi_id","subj":"T494","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A495","pred":"chebi_id","subj":"T495","obj":"http://purl.obolibrary.org/obo/CHEBI_3435"}],"text":"d for COVID-19 using the envelope protein of SARS-CoV-2 as an immunogenic target [124]. Carrageenan and its structurally related compounds may se"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T949","span":{"begin":6,"end":14},"obj":"SP_7"},{"id":"T950","span":{"begin":25,"end":33},"obj":"GO:0031975"},{"id":"T951","span":{"begin":45,"end":55},"obj":"SP_7"},{"id":"T952","span":{"begin":62,"end":73},"obj":"CHEBI:60816;CHEBI:60816"},{"id":"T953","span":{"begin":88,"end":99},"obj":"CHEBI:3435;CHEBI:3435"},{"id":"T954","span":{"begin":129,"end":138},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T72359","span":{"begin":27,"end":42},"obj":"CHEBI:18154;CHEBI:18154"},{"id":"T61413","span":{"begin":89,"end":103},"obj":"CHEBI:18154;CHEBI:18154"},{"id":"T86563","span":{"begin":104,"end":113},"obj":"CHEBI:60809;CHEBI:60809"}],"text":"d for COVID-19 using the envelope protein of SARS-CoV-2 as an immunogenic target [124]. Carrageenan and its structurally related compounds may se"}

    MyTest

    {"project":"MyTest","denotations":[{"id":"1121","span":{"begin":45,"end":55},"obj":"Species"},{"id":"1124","span":{"begin":88,"end":99},"obj":"Chemical"},{"id":"1131","span":{"begin":6,"end":14},"obj":"Disease"}],"attributes":[{"id":"A1121","pred":"tao:has_database_id","subj":"1121","obj":"Tax:2697049"},{"id":"A1124","pred":"tao:has_database_id","subj":"1124","obj":"MESH:D002351"},{"id":"A1131","pred":"tao:has_database_id","subj":"1131","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"d for COVID-19 using the envelope protein of SARS-CoV-2 as an immunogenic target [124]. Carrageenan and its structurally related compounds may se"}